Michigan Community Vna | |
30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan 48025 | |
(800) 882-5720 | |
Name | Michigan Community Vna |
---|---|
Location | 30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 237016 |
Ownership Type | Proprietary |
Service Area Zip Codes | 48005, 48009, 48015, 48017, 48021, 48025, 48026, 48030, 48033, 48034, 48035, 48036, 48038, 48042, 48043, 48044, 48045, 48047, 48050, 48051, 48062, 48065, 48066, 48067, 48071, 48072, 48073, 48075, 48076, 48080, 48081, 48082, 48083, 48084, 48085, 48088, 48089, 48091, 48092, 48093, 48094, 48098, 48101, 48103, 48111, 48114, 48116, 48120, 48122, 48124, 48125, 48126, 48127, 48128, 48134, 48135, 48141, 48146, 48150, 48152, 48154, 48165, 48167, 48168, 48170, 48174, 48178, 48180, 48183, 48184, 48185, 48186, 48187, 48188, 48189, 48193, 48195, 48197, 48198, 48201, 48202, 48203, 48204, 48205, 48206, 48207, 48208, 48209, 48210, 48211, 48212, 48213, 48214, 48215, 48216, 48218, 48219, 48220, 48221, 48223, 48224, 48225, 48227, 48228, 48230, 48234, 48235, 48236, 48237, 48238, 48239, 48240, 48301, 48302, 48304, 48306, 48307, 48309, 48310, 48312, 48313, 48314, 48315, 48316, 48317, 48322, 48323, 48324, 48326, 48327, 48328, 48329, 48331, 48334, 48335, 48336, 48340, 48341, 48342, 48346, 48357, 48359, 48362, 48363, 48374, 48375, 48377, 48381, 48382, 48383, 48386, 48390, 48414, 48418, 48429, 48430, 48438, 48439, 48446, 48451, 48476, 48504, 48505, 48507, 48532, 48808, 48813, 48817, 48819, 48820, 48821, 48823, 48827, 48831, 48835, 48836, 48837, 48840, 48842, 48843, 48844, 48848, 48853, 48854, 48855, 48857, 48861, 48864, 48866, 48867, 48872, 48875, 48879, 48890, 48892, 48894, 48895, 48906, 48910, 48911, 48912, 48915, 48917, 48933, 49073, 49096, 49201, 49202, 49203, 49246, 49251, 49264, 49277, 49284 |
NPI Number | 1699010553 |
Organization Name | MICHIGAN COMMUNITY VNA, LLC |
Doing Business As | MICHIGAN COMMUNITY VNA |
Address | 30800 Telegraph Rd., Suite 1728, Bingham Farms, MI 48025 |
Phone Number | 248-967-1440 |
News Archive
Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.
› Verified 4 days ago
Quality Rating: |
News Archive
Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 98.9 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 99.9 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 84.4 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.2 | 96.4 |
News Archive
Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 79.7 | 79.6 |
How often patients got better at getting in and out of bed | 80.8 | 81.1 |
How often patients got better at bathing | 83.5 | 82.3 |
How often patients’ breathing improved | 84.6 | 82.8 |
How often patients’ wounds improved or healed after an operation | 72.3 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 74.6 | 75 |
How often home health patients had to be admitted to the hospital | 15.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 10.2 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 98.9 | 94 |
News Archive
Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.
› Verified 4 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.
› Verified 4 days ago
The patient survey data of Michigan Community Vna is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 82 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 73 | 78 |
News Archive
Air pollution - even at levels below national and international air quality guidelines - is associated with an increased risk of deaths in Canada, according to new UBC research.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced updated clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor, presented during two oral presentations at the 51st American Society of Hematology Annual Meeting in New Orleans.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present, via diagnostics such as PET scans, and possibly offers an avenue for novel cancer therapies.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
ZIOPHARM Oncology, Inc. announced today that it has received an allowance from the European Patent Office for Patent Application No. 05 821 125.1, entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to pharmaceutical compositions of a novel DNA cross-linker, including palifosfamide and their use in treating cancer.
› Verified 4 days ago
Michigan Community Vna Location: 30800 Telegraph Rd, Suite 1728, Bingham Farms, Michigan 48025 Ratings: Phone: (800) 882-5720 | |
Professional Home Care Location: 30600 Telegraph, Suite 3140, Bingham Farms, Michigan 48025 Ratings: Phone: (313) 294-9220 | |
Optimal Care Location: 30600 Telegraph Road, Suite 3275, Bingham Farms, Michigan 48025 Ratings: Phone: (248) 723-9613 | |
John Paul Home Health Care Location: 30800 Telegraph Rd #3700, Bingham Farms, Michigan 48025 Ratings: Phone: (248) 731-7457 | |
Supportive Home Health Care Location: 30100 Telegraph Rd, Suite 478, Bingham Farms, Michigan 48025 Ratings: Phone: (248) 291-5806 | |
Elara Caring Location: 30400 Telegraph Rd, Suite 334, Bingham Farms, Michigan 48025 Ratings: Phone: (734) 525-4830 |